16-11742565-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015914.7(TXNDC11):āc.166T>Cā(p.Phe56Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,456,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015914.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNDC11 | NM_015914.7 | c.166T>C | p.Phe56Leu | missense_variant | 1/12 | ENST00000283033.10 | NP_056998.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNDC11 | ENST00000283033.10 | c.166T>C | p.Phe56Leu | missense_variant | 1/12 | 2 | NM_015914.7 | ENSP00000283033 | P2 | |
TXNDC11-AS1 | ENST00000572811.1 | n.656A>G | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 151986Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.00000843 AC: 11AN: 1304666Hom.: 0 Cov.: 35 AF XY: 0.0000109 AC XY: 7AN XY: 642720
GnomAD4 genome AF: 0.000118 AC: 18AN: 152094Hom.: 0 Cov.: 34 AF XY: 0.000134 AC XY: 10AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.166T>C (p.F56L) alteration is located in exon 1 (coding exon 1) of the TXNDC11 gene. This alteration results from a T to C substitution at nucleotide position 166, causing the phenylalanine (F) at amino acid position 56 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at